Valneva SE (VALN) EBITDA Margin Growth (3y) (2024 - 2026)
Valneva SE (VALN) EBITDA Margin Growth (3y) (2024 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Valneva SE |
167.33 Mn |
44.10 Mn |
5.08 Mn |
-2,132.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,132.00 |
| Dec 31, 2025 |
-9.39 Mn |
| Sep 30, 2025 |
9.20 Mn |
| Jun 30, 2025 |
67,207.00 |
| Mar 31, 2025 |
11,261.00 |
| Dec 31, 2024 |
-103,697.00 |
| Sep 30, 2024 |
108,758.00 |
| Jun 30, 2024 |
28,475.00 |
| Mar 31, 2024 |
40,258.00 |
